BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines

American Journal of Pathology

Volumn 176, Issue 3, 2010, Pages 1203-1214

  Tulchin, Natalie ^a   Chambon, Monique ^b   Juan, Gloria ^c,d   Dikman, Steven ^a   Strauchen, James ^a   Ornstein, Leonard ^a   Billack, Blase ^e   Woods, Nicholas T ^f   Monteiro, Alvaro N A ^f  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b INSERM   (France)

^c CENTRE VAL D AURELLE   (France)

^d AMGEN INC   (United States)

^e ST JOHN'S UNIVERSITY   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; DNA; NUCLEOLIN; SMALL INTERFERING RNA;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPATHOLOGY; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

EID: 77749273747     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.081063     Document Type: Article

References (50)

1. Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, King MC: Frequency of breast cancer attributable to BRCA1 in a population based series of American women. JAMA 1998, 279:915-921
2. Miki Y, Swensen J, Shattuck-Eidens D, Futreal A, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal JA, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Christian W, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lei M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266:66-71
3. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swense J, Teng D, Thomas A, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AK, Shizuya H, Eyfjord JE, Cannon-Albright L, Tranchant M, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE: :The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996, 12:333-337
4. Merajver SD, Frank TS, Xu J, Pham T, Calzone KA, Bennett-Baker P, Chamberlain J, Boyd J, Garber JE, Collins FS, Weber BL: Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Clin Cancer Res 1995, 1:539-544
5. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Terry L: Jhanwar S. Berchuck A, Iglehart D, Marks J, Ballinger DG, Barrett JC, Skolnick MH Kamb A, Wiseman R: bRCA1 mutations in primary breast and ovarian carcinomas. Science 1994, 266:120-122
6. Ozcelik H, To MD, Couture J, Bull SB, Andrulis IL: Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. Int J Cancer 1998, 77:1-6
7. Sourvinos G, Spandidos DA: Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Biochem Biophys Res Commun 1998, 245:75-80
8. Rio PG, Maurizis J-C, de Latour MP, Bignon YJ, Bernard-Gallon DJ: Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene. Int J Cancer 1999, 80:823-826
9. Rakha EA, El-Sheikh SE, Kandil MA, El-Sayed ME, Green AR, Ellis IO: Expression of BRCA1 protein in breast cancer and its prognostic significance. Hum Pathol 2008, 39:857-865
10. Wilson CA, Payton MN, Pekar SK, Zhang K, Pacific RE, Gudas JL, Thukral S, Calzone FJ, Reese DM, Slamon DI: BRCA1 protein products: antibody specificity. Nat Genet 1996, 13:264-265
11. Narod SA, Foulkes WD: BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004, 4:665-676
12. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM: Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997, 90:425-435
13. Tulchin N, Ornstein L, Bleiweiss IJ, Mendlowitz M, Weinstein E, Dikman SH: Nucleolar localization of BRCA1 protein in human breast cancer. Int J Oncol 1998, 13:513-518
14. Chambon M, Nirde P, Gleizes M, Roger P, Vignon F: Localization of BRCA1 protein in human breast cancer cells. Breast Cancer Res Treat 2003, 79:107-119
15. Lotti LV, Ottini L, D'Amico C, Gradini R, Belleudi CA, Frati L, Tomsi MR, Mariani-Costantini R: Subcellular localization of the BRCA1 gene product in mitotic cells. Genes Chromosomes Cancer 2002, 35:193-203
16. Coene ED, Hollinshead MS, Waeytens. AT, Schelfhout VRJ, Eechaute WP, Shaw MK, Van Oostveldt PMV, Vaux DJ: Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria. Mol Biol Cell 2005, 16:997-1010
17. Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, Mok SC, Randrianarison V, Brodie S, Salstrom J, Rasmussen TP, Klimke A, Marrese C, Marahrens Y, Deng CX, Feunteun J, Livingston DM: BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 2002, 111:393-405
18. Silver DP, Dimitrov SD, Feunteun J, Gelman R, Drapkin R, Lu SD, Shestakova E, Velmurugan S, DeNunzio N: Dragomir S. Mar J, Liu X, Rottenberg, Jonkers J, Ganesan S, Livingston DM: Further evidence for BRCA1 communication with the inactive X chromosome Cell 2007, 128:991-1002
19. Association of Directors of Anatomic and Surgical Pathology: Recommendations for the reporting of breast carcinoma. Mod Pathol 1996, 9:77-81
20. Scully R, Ganesan S, Brown M, De Caprio JA, Cannistra SA, Feunteun J: Location of BRCA1 in human breast and ovarian cancer cells. Science 1996, 272:123-125
21. De Petrocellis L, Melck D, Palmisano A, Bisogno T, LaezzA C, Bifulco M, Di Marzo V: The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA 1998, 95:8375-8380
22. Pinol-Roma S: Association of non-ribosomal nucleolar proteins in ribonucleoprotein complexes during interphase and mitosis. Mol Biol Cell 1999, 10:77-90
23. Juan G, Cordon-Cardo C: Intranuclear compartmentalization of cyclin E during the cell cycle: disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer. Cancer Res 2001, 61:1220-1226
24. Brummelkamp TR, Bernards R, Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296:550-553
25. Thomas JE, Smith M, Rubinfeld B, Gutowski M, Beckmann RP, Polakis P: Subcellular localization and analysis of apparent 180kD and 220kD protein of the breast cancer susceptibility gene. BRCA1 J Biol Chem 1996, 271:28630-28635
26. Hadjisavvas A, Mikellidou C, Zenios A, Zouvani I, Adamou A, Christodoulous C, Kyriacou K: Correlation between morphology, immunohistochemistry, and molecular pathology in hereditary and sporadic breast cancer cases. Ultrastruct Pathol 2002, 26:237-244
27. Aglipay JA, Lee SW, Okada S, Fujiuchi N, Ohtsuka T, Kwak JC, Wang Y, Johnstone RW, Deng C, Qin J, Ouchi T: A member of the pyrin family. IF116, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway. Oncogene 2003, 22:8931-8936
28. Alberts B, Wilson J, Johnson H, Lewis J, Raff M, Roberts K: Molecular Biology of the Cell. Fifth Ed. Garland Science, 2007, pp 382
29. Shiohama A, Sasaki T, Noda S, Minoshima S, Shimizu N: Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. Exp Cell Res 2007, 313:4196-4207
30. Monneron A, Bernhard W: Fine structural organization of the interphase nucleus in some mammalian cells. J Ultrastructural Res 1969, 27:266-288
31. Carmo-Fonseca M, Pepperkok R, Carvalho MT, Lamond AI: Transcription-dependent colocalization of the U1, U2, U4/U6, U5 snRNPs in coiled bodies. J Cell Biol 1992, 117:1-14
32. Andersen JS, Lyon CE, Fox AH, Leung AKL, Lam YW, Steen MM, Lamond AI: Directed proteomic analysis of the human nucleolus. Curr Biol 2002, 12:1-11
33. Scherl A, Coute Y, Deon C, Calle A, Kindbeiter K, Sanchez J-C, Greco A, Hochstrasser D, Diaz J-J: Functional proteomic analysis of human nucleolus. Mol Biol Cell 2002, 13:4100-4109
34. Leung AK, Andersen JS, Mann M, Lamond AI: Bioinformatic analysis of the nucleolus. Biochem J 2003, 376:553-569
35. Politz JCR, Polena I, Trask I, Bazett-Jones DP, Pederson T: A nonribosomal landscape in the nucleolus revealed by the stem cell protein nucleostemin. Mol Biol Cell 2005, 16:3401-3410
36. Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, Lamond AI, Mann M: Nucleolar proteome dynamics. Nature 2005, 433:77-83
37. Monteiro AN: BRCA1: exploring the links to transcription. Trends Biochem Sci 2000, 25:469-474
38. Guo Z, Qian L, Liu R, Dai H, Zhou M, Zheng L, Shen B: Nucleolar localization and dynamic roles of flap endonuclease I in ribosomal DNA replication and damage repair. Mol Biol Cell 2008, 28:4310-4319
39. Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM: BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci USA 1997, 94:5605-5610
40. Schlegel BP, Green VJ, Ladias JA, Parvin JD: BRCA1 interaction with RNA polymerase II reveals a role for hRPB2 and hRB10α in activated transcription. Proc Natl Acad Sci USA 2000, 97:3148-153
41. Shpakovski GV, Acker J, Wintzerith M, Lacroix JF, Thuriaux P, Vigneron M: Four subunits that are shared by three classes of RNA polymerase are functionally interchangeable between Homo sapiens and Saccharomyces cerevisiae. Mol Cell Biol 1995, 9:4702-4710
42. Hölzel M, Grimm T, Rohrmoser M, Malamoussi A, Harasim T, Gruber-Eber A, Kremmer E, Eick D: The BRCT domain of mammalian Pes1 is crucial for nucleolar localization and rRNA processing. Nucleic Acids Res 2007, 35:789-800
43. Adams CC, Jakovljevic J, Roman J, Hampichamchai P, Woolford JL: Saccharomyces cerevisiae nucleolar protein Nop7p is necessary for biogenesis of 60S ribosomal subunits. RNA 2002, 8:150-165
44. Carvalho MA, Marsillac SM, Karchin R, Manoukian S, Grist S, Swaby RF, Urmenyi TP, Rondinelli E, Silva R, Gayol L, Baumbach L, Sutphen R, Pickard-Brzosowicz JL, Nathanson KL, Sali A, Goldgar D, Couch FJ, Radice P, Monteiro AN: Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. Cancer Res 2007, 67:1494-1501
45. Ouchi T, Monteiro AN, August A, Aaronson SA, Hanafusa H: BRCA1 regulates p-53 dependent gene expression. Proc Natl Acad Sci USA 1998, 95:2302-2306
46. Zhang H, Somasundaram K, Peng Y, Tian H, Zhang H, Bi D, Weber BL, El-Deiry WS: BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 1998, 16:1713-1721
47. Budde A, Grummt I: p53 represses ribosomal gene transcription. Oncogene 1999, 18:1119-1124
48. Zhai W, Comai L: Repression of RNA polymerase I transcription by the tumor suppressor p53. Mol Cell Biol 2000, 20:5930-5938
49. Somasundaram K, MacLachlan TK, Burns TF, Sgagias M, Cowan KH, Weber BL, el-Deiry WS: BRCA1 signals ARF-dependent stabilization and coactivation of p53. Oncogene 1999, 18:6605-6614
50. Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992, 69: 1237-1245